BIAF vs. HLGN, SKYQ, SUGP, TDTH, WAI, ONMD, LUNA, STFS, HTCR, and MSPR
Should you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include Heliogen (HLGN), Sky Quarry (SKYQ), SU Group (SUGP), Trident Digital Tech (TDTH), Top KingWin (WAI), OneMedNet (ONMD), Luna Innovations (LUNA), Star Fashion Culture (STFS), HeartCore Enterprises (HTCR), and MSP Recovery (MSPR). These companies are all part of the "business services" industry.
bioAffinity Technologies vs.
bioAffinity Technologies (NASDAQ:BIAF) and Heliogen (NYSE:HLGN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, community ranking, valuation, profitability, dividends and risk.
bioAffinity Technologies has a beta of 3.01, suggesting that its stock price is 201% more volatile than the S&P 500. Comparatively, Heliogen has a beta of 2.66, suggesting that its stock price is 166% more volatile than the S&P 500.
Heliogen has a net margin of 0.00% compared to bioAffinity Technologies' net margin of -91.22%. Heliogen's return on equity of 0.00% beat bioAffinity Technologies' return on equity.
bioAffinity Technologies presently has a consensus price target of $6.00, suggesting a potential upside of 2,079.44%. Given bioAffinity Technologies' stronger consensus rating and higher probable upside, analysts clearly believe bioAffinity Technologies is more favorable than Heliogen.
1.6% of bioAffinity Technologies shares are owned by institutional investors. Comparatively, 27.6% of Heliogen shares are owned by institutional investors. 35.1% of bioAffinity Technologies shares are owned by company insiders. Comparatively, 3.8% of Heliogen shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
In the previous week, Heliogen had 1 more articles in the media than bioAffinity Technologies. MarketBeat recorded 1 mentions for Heliogen and 0 mentions for bioAffinity Technologies. bioAffinity Technologies' average media sentiment score of 0.00 equaled Heliogen'saverage media sentiment score.
bioAffinity Technologies has higher revenue and earnings than Heliogen. bioAffinity Technologies is trading at a lower price-to-earnings ratio than Heliogen, indicating that it is currently the more affordable of the two stocks.
bioAffinity Technologies received 1 more outperform votes than Heliogen when rated by MarketBeat users. Likewise, 50.00% of users gave bioAffinity Technologies an outperform vote while only 0.00% of users gave Heliogen an outperform vote.
Summary
bioAffinity Technologies beats Heliogen on 9 of the 16 factors compared between the two stocks.
Get bioAffinity Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
bioAffinity Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:BIAF) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy BIAF Stock Free BIAF Stock Alerts